175 related articles for article (PubMed ID: 11288756)
1. B-cell kinase lyn deficiency in patients with systemic lupus erythematosus.
Liossis SN; Solomou EE; Dimopoulos MA; Panayiotidis P; Mavrikakis MM; Sfikakis PP
J Investig Med; 2001 Mar; 49(2):157-65. PubMed ID: 11288756
[TBL] [Abstract][Full Text] [Related]
2. Expression of B cell receptor-associated signaling molecules in human lupus.
Huck S; Le Corre R; Youinou P; Zouali M
Autoimmunity; 2001 May; 33(3):213-24. PubMed ID: 11683380
[TBL] [Abstract][Full Text] [Related]
3. Decreased Lyn expression and translocation to lipid raft signaling domains in B lymphocytes from patients with systemic lupus erythematosus.
Flores-Borja F; Kabouridis PS; Jury EC; Isenberg DA; Mageed RA
Arthritis Rheum; 2005 Dec; 52(12):3955-65. PubMed ID: 16320343
[TBL] [Abstract][Full Text] [Related]
4. Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection.
Cornall RJ; Cyster JG; Hibbs ML; Dunn AR; Otipoby KL; Clark EA; Goodnow CC
Immunity; 1998 Apr; 8(4):497-508. PubMed ID: 9586639
[TBL] [Abstract][Full Text] [Related]
5. Altered lipid raft-associated proximal signaling and translocation of CD45 tyrosine phosphatase in B lymphocytes from patients with systemic lupus erythematosus.
Flores-Borja F; Kabouridis PS; Jury EC; Isenberg DA; Mageed RA
Arthritis Rheum; 2007 Jan; 56(1):291-302. PubMed ID: 17195233
[TBL] [Abstract][Full Text] [Related]
6. Altered recruitment of Lyn, Syk and ZAP-70 into lipid rafts of activated B cells in Systemic Lupus Erythematosus.
Vásquez A; Baena A; González LA; Restrepo M; Muñoz CH; Vanegas-García A; Ortiz-Reyes B; Abdoel N; Rojas M; García LF; Vásquez G
Cell Signal; 2019 Jun; 58():9-19. PubMed ID: 30840855
[TBL] [Abstract][Full Text] [Related]
7. Signaling mutations and autoimmunity.
Yu CC; Mamchak AA; DeFranco AL
Curr Dir Autoimmun; 2003; 6():61-88. PubMed ID: 12408047
[TBL] [Abstract][Full Text] [Related]
8. Differential control of CD22 ligand expression on B and T lymphocytes, and enhanced expression in murine systemic lupus.
Lajaunias F; Ida A; Kikuchi S; Fossati-Jimack L; Martinez-Soria E; Moll T; Law CL; Izui S
Arthritis Rheum; 2003 Jun; 48(6):1612-21. PubMed ID: 12794829
[TBL] [Abstract][Full Text] [Related]
9. Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus.
Iwata S; Yamaoka K; Niiro H; Jabbarzadeh-Tabrizi S; Wang SP; Kondo M; Yoshikawa M; Akashi K; Tanaka Y
Lupus; 2015 Jun; 24(7):695-704. PubMed ID: 25432781
[TBL] [Abstract][Full Text] [Related]
10. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production.
Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y
Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077
[TBL] [Abstract][Full Text] [Related]
11. Enhanced Tyrosine Phosphatase Activity Underlies Dysregulated B Cell Receptor Signaling and Promotes Survival of Human Lupus B Cells.
Fleischer SJ; Daridon C; Fleischer V; Lipsky PE; Dörner T
Arthritis Rheumatol; 2016 May; 68(5):1210-21. PubMed ID: 26713408
[TBL] [Abstract][Full Text] [Related]
12. A double-edged kinase Lyn: a positive and negative regulator for antigen receptor-mediated signals.
Nishizumi H; Horikawa K; Mlinaric-Rascan I; Yamamoto T
J Exp Med; 1998 Apr; 187(8):1343-8. PubMed ID: 9547345
[TBL] [Abstract][Full Text] [Related]
13. B cell receptor signaling in human systemic lupus erythematosus.
Pugh-Bernard AE; Cambier JC
Curr Opin Rheumatol; 2006 Sep; 18(5):451-5. PubMed ID: 16896281
[TBL] [Abstract][Full Text] [Related]
14. Increased mutations of CD72 transcript in B-lymphocytes from adolescent patients with systemic lupus erythematosus.
Kaneko U; Toyabe S; Hara M; Uchiyama M
Pediatr Allergy Immunol; 2006 Dec; 17(8):565-71. PubMed ID: 17121583
[TBL] [Abstract][Full Text] [Related]
15. Low-grade non-Hodgkin's lymphoma in a patient with systemic lupus erythematosus.
Robak T; Robak E; Bartkowiak J; Błoński JZ; Niewiadomska H; Wawrzyniak E
Leuk Lymphoma; 2001 May; 41(5-6):659-67. PubMed ID: 11378584
[TBL] [Abstract][Full Text] [Related]
16. Lyn, Lupus, and (B) Lymphocytes, a Lesson on the Critical Balance of Kinase Signaling in Immunity.
Brodie EJ; Infantino S; Low MSY; Tarlinton DM
Front Immunol; 2018; 9():401. PubMed ID: 29545808
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with Lyn.
Liu Y; Dong J; Mu R; Gao Y; Tan X; Li Y; Li Z; Yang G
Arthritis Rheum; 2013 Jun; 65(6):1603-11. PubMed ID: 23450709
[TBL] [Abstract][Full Text] [Related]
18. CD19/22 balance relates to improvement of disease activity in systemic lupus erythematosus.
Suzuki J; Nakano S; Nakairi Y; Mitsuo A; Amano H; Morimoto S; Tokano Y; Takasaki Y
Mod Rheumatol; 2006; 16(4):235-8. PubMed ID: 16906374
[TBL] [Abstract][Full Text] [Related]
19. Regulation of B cell antigen receptor signaling by the Lyn/CD22/SHP1 pathway.
Cornall RJ; Goodnow CC; Cyster JG
Curr Top Microbiol Immunol; 1999; 244():57-68. PubMed ID: 10453649
[No Abstract] [Full Text] [Related]
20. Up-regulation of transcription factor Blimp1 in systemic lupus erythematosus.
Luo J; Niu X; Liu H; Zhang M; Chen M; Deng S
Mol Immunol; 2013 Dec; 56(4):574-82. PubMed ID: 23911415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
